SCHEMBL7835720

SCHEMBL7835720

Cc1cc(=O)n(Cc2ccccc2)c(=O)n1Cc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.69
HPGD P15428 1/20 0.59
MEN1 O00255 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MAPK1 P28482 1/20 0.55
NOTUM Q6P988 1/20 0.53
ATM Q13315 1/20 0.53
C5AR1 P21730 1/20 0.53
CYP3A4 P08684 1/20 0.51
ALDH1A1 P00352 3/20 0.51
MAPT P10636 3/20 0.51
LMNA P02545 1/20 0.51
GRIA2 P42262 1/20 0.49
BCHE P06276 1/20 0.49
ACHE P22303 1/20 0.49
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7831973 0.86 KMT2A (0.55) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL7830685 0.86 KMT2A (0.58) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL11730687 0.85 HPGD (0.59) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL4490722 0.85 KMT2A (0.64) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL4766008 0.83 KMT2A (0.54) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL14038766 0.82 KMT2A (0.56) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL19755863 0.81 LOXL2 (0.54) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL8985073 0.80 GSK3B (0.67) KMT2AHPGDMEN1SMN1; SMN2C5AR1
SCHEMBL13932417 0.80 KMT2A (0.48) KMT2AHPGDMEN1SMN1; SMN2MAPK1
SCHEMBL4769071 0.80 ALDH1A1 (0.60) KMT2AMEN1SMN1; SMN2MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed